Been in for awhile and looks to be breaking out of the current range with volume. Could a large short position and squeeze finally be in the cards??? Catalysts are upcoming European approval for expanded use of their new drug Neudexta and in court, the Generic manufacturers hopefully will be denied access to make the patented formula. Lots of Institutional ownership. High Beta stock! Week over week sales % is encouraging. I beleive there is a 14 dollar target out there somewhere. GLTA, sure could use a winner......